510(k) K081615

OLYMPUS CEA - CARCINOEMBRYONIC ANTIGEN by Olympus America, Inc. — Product Code DHX

K081615 is an FDA 510(k) premarket notification submitted by Olympus America, Inc. for the device "OLYMPUS CEA - CARCINOEMBRYONIC ANTIGEN". The FDA issued a decision of Substantially Equivalent on March 18, 2009. The device falls under product code DHX (System, Test, Carcinoembryonic Antigen), a Class II device regulated under 21 CFR 866.6010. Olympus America, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
March 18, 2009
Date Received
June 9, 2008
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Test, Carcinoembryonic Antigen
Device Class
Class II
Regulation Number
866.6010
Review Panel
IM
Submission Type